Abstract
Most patients of LMCA disease are symptomatic and at high risk of cardiovascular (CV) events, since occlusion compromises flow, and it is associated with >20% mortality at 1 year. Coronary artery by-pass graft (CABG) is the main mode of revascularization procedure for significant left-main coronary artery (LMCA) disease unless contraindicated or unsuitable for surgery, and in patients with complex coronary anatomy. Percutaneous coronary intervention (PCI) of left-main (LM) is emerging as an alternative to CABG especially in patients with low syntax score with suitable coronary anatomy for PCI, and life-saving emergency situations like acute coronary syndrome (ACS) with hemodynamically unstable, and high risk group patients who are unsuitable coronary anatomy for grafting or due to associated co-morbidities.